Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
   C01 CARDIAC THERAPY
   C02 ANTIHYPERTENSIVES
   C03 DIURETICS
   C04 PERIPHERAL VASODILATORS
   C05 VASOPROTECTIVES
   C07 BETA BLOCKING AGENTS
   C08 CALCIUM CHANNEL BLOCKERS
   C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
   C10 LIPID MODIFYING AGENTS
     C10A LIPID MODIFYING AGENTS, PLAIN
       C10AA HMG CoA reductase inhibitors [DG:DG01660]
       C10AB Fibrates
       C10AC Bile acid sequestrants
       C10AD Nicotinic acid and derivatives
       C10AX Other lipid modifying agents
         C10AX01 Dextrothyroxine
         C10AX02 Probucol
           D00476  Probucol (JP18/USP/INN) <JP>
         C10AX03 Tiadenol
         C10AX05 Meglutol
         C10AX06 Omega-3-triglycerides incl. other esters and acids
         C10AX07 Magnesium pyridoxal 5-phosphate glutamate
         C10AX08 Policosanol
         C10AX09 Ezetimibe
         C10AX10 Alipogene tiparvovec
         C10AX11 Mipomersen
         C10AX12 Lomitapide [DG:DG00362]
         C10AX13 Evolocumab
         C10AX14 Alirocumab
         C10AX15 Bempedoic acid
         C10AX16 Inclisiran [DG:DG03216]
         C10AX17 Evinacumab
         C10AX18 Volanesorsen [DG:DG03070]
     C10B LIPID MODIFYING AGENTS, COMBINATIONS
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: March 6, 2024
According to WHO's ATC 2024

» Japanese version